Global Pure EPA Active Pharmaceutical Ingredient (API) Supply, Demand and Key Producers, 2024-2030
The global Pure EPA Active Pharmaceutical Ingredient (API) market size is expected to reach $ 632.7 million by 2030, rising at a market growth of 10.4% CAGR during the forecast period (2024-2030).
Eicosapentaenoic acid (EPA; also icosapentaenoic acid) is an omega-3 fatty acid. It is obtained in the human diet by eating oily fish or fish oil, e.g. cod liver, herring, mackerel, salmon, menhaden and sardine, and various types of edible algae. EPA is used as a prescription medicine to reduce triglyceride levels.
This report studies Pure EPA (96.5% purity or higher).
This report studies the global Pure EPA Active Pharmaceutical Ingredient (API) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pure EPA Active Pharmaceutical Ingredient (API), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pure EPA Active Pharmaceutical Ingredient (API) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pure EPA Active Pharmaceutical Ingredient (API) total production and demand, 2019-2030, (Tons)
Global Pure EPA Active Pharmaceutical Ingredient (API) total production value, 2019-2030, (USD Million)
Global Pure EPA Active Pharmaceutical Ingredient (API) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Pure EPA Active Pharmaceutical Ingredient (API) consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: Pure EPA Active Pharmaceutical Ingredient (API) domestic production, consumption, key domestic manufacturers and share
Global Pure EPA Active Pharmaceutical Ingredient (API) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global Pure EPA Active Pharmaceutical Ingredient (API) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Pure EPA Active Pharmaceutical Ingredient (API) production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).
This reports profiles key players in the global Pure EPA Active Pharmaceutical Ingredient (API) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KD Pharma, Nippon Suisan Kaisha, Bizen Chemical, AK Biopharm, Maruha Nichiro and Croda Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pure EPA Active Pharmaceutical Ingredient (API) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Pure EPA Active Pharmaceutical Ingredient (API) Market, By Region:
1. How big is the global Pure EPA Active Pharmaceutical Ingredient (API) market?
2. What is the demand of the global Pure EPA Active Pharmaceutical Ingredient (API) market?
3. What is the year over year growth of the global Pure EPA Active Pharmaceutical Ingredient (API) market?
4. What is the production and production value of the global Pure EPA Active Pharmaceutical Ingredient (API) market?
5. Who are the key producers in the global Pure EPA Active Pharmaceutical Ingredient (API) market?
Eicosapentaenoic acid (EPA; also icosapentaenoic acid) is an omega-3 fatty acid. It is obtained in the human diet by eating oily fish or fish oil, e.g. cod liver, herring, mackerel, salmon, menhaden and sardine, and various types of edible algae. EPA is used as a prescription medicine to reduce triglyceride levels.
This report studies Pure EPA (96.5% purity or higher).
This report studies the global Pure EPA Active Pharmaceutical Ingredient (API) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pure EPA Active Pharmaceutical Ingredient (API), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pure EPA Active Pharmaceutical Ingredient (API) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pure EPA Active Pharmaceutical Ingredient (API) total production and demand, 2019-2030, (Tons)
Global Pure EPA Active Pharmaceutical Ingredient (API) total production value, 2019-2030, (USD Million)
Global Pure EPA Active Pharmaceutical Ingredient (API) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Pure EPA Active Pharmaceutical Ingredient (API) consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: Pure EPA Active Pharmaceutical Ingredient (API) domestic production, consumption, key domestic manufacturers and share
Global Pure EPA Active Pharmaceutical Ingredient (API) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global Pure EPA Active Pharmaceutical Ingredient (API) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Pure EPA Active Pharmaceutical Ingredient (API) production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).
This reports profiles key players in the global Pure EPA Active Pharmaceutical Ingredient (API) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KD Pharma, Nippon Suisan Kaisha, Bizen Chemical, AK Biopharm, Maruha Nichiro and Croda Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pure EPA Active Pharmaceutical Ingredient (API) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Pure EPA Active Pharmaceutical Ingredient (API) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Purity 96.5%
- Purity 99%
- Hypolipidemic Drugs
- Cardiovascular Disease Drugs
- KD Pharma
- Nippon Suisan Kaisha
- Bizen Chemical
- AK Biopharm
- Maruha Nichiro
- Croda Pharma
1. How big is the global Pure EPA Active Pharmaceutical Ingredient (API) market?
2. What is the demand of the global Pure EPA Active Pharmaceutical Ingredient (API) market?
3. What is the year over year growth of the global Pure EPA Active Pharmaceutical Ingredient (API) market?
4. What is the production and production value of the global Pure EPA Active Pharmaceutical Ingredient (API) market?
5. Who are the key producers in the global Pure EPA Active Pharmaceutical Ingredient (API) market?
1 SUPPLY SUMMARY
1.1 Pure EPA Active Pharmaceutical Ingredient (API) Introduction
1.2 World Pure EPA Active Pharmaceutical Ingredient (API) Supply & Forecast
1.2.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value (2019 & 2023 & 2030)
1.2.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.2.3 World Pure EPA Active Pharmaceutical Ingredient (API) Pricing Trends (2019-2030)
1.3 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Region (Based on Production Site)
1.3.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Region (2019-2030)
1.3.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Region (2019-2030)
1.3.3 World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Region (2019-2030)
1.3.4 North America Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.3.5 Europe Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.3.6 Japan Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.3.7 South Korea Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pure EPA Active Pharmaceutical Ingredient (API) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pure EPA Active Pharmaceutical Ingredient (API) Major Market Trends
2 DEMAND SUMMARY
2.1 World Pure EPA Active Pharmaceutical Ingredient (API) Demand (2019-2030)
2.2 World Pure EPA Active Pharmaceutical Ingredient (API) Consumption by Region
2.2.1 World Pure EPA Active Pharmaceutical Ingredient (API) Consumption by Region (2019-2024)
2.2.2 World Pure EPA Active Pharmaceutical Ingredient (API) Consumption Forecast by Region (2025-2030)
2.3 United States Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.4 China Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.5 Europe Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.6 Japan Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.7 South Korea Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.8 ASEAN Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.9 India Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
3 WORLD PURE EPA ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Manufacturer (2019-2024)
3.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Manufacturer (2019-2024)
3.3 World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Manufacturer (2019-2024)
3.4 Pure EPA Active Pharmaceutical Ingredient (API) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pure EPA Active Pharmaceutical Ingredient (API) in 2023
3.5.3 Global Concentration Ratios (CR8) for Pure EPA Active Pharmaceutical Ingredient (API) in 2023
3.6 Pure EPA Active Pharmaceutical Ingredient (API) Market: Overall Company Footprint Analysis
3.6.1 Pure EPA Active Pharmaceutical Ingredient (API) Market: Region Footprint
3.6.2 Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Type Footprint
3.6.3 Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Value Comparison
4.1.1 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Comparison
4.2.1 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Consumption Comparison
4.3.1 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value (2019-2024)
4.4.3 United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024)
4.5 China Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers and Market Share
4.5.1 China Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value (2019-2024)
4.5.3 China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024)
4.6 Rest of World Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Pure EPA Active Pharmaceutical Ingredient (API) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Purity 96.5%
5.2.2 Purity 99%
5.3 Market Segment by Type
5.3.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Type (2019-2030)
5.3.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type (2019-2030)
5.3.3 World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pure EPA Active Pharmaceutical Ingredient (API) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hypolipidemic Drugs
6.2.2 Cardiovascular Disease Drugs
6.3 Market Segment by Application
6.3.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Application (2019-2030)
6.3.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application (2019-2030)
6.3.3 World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 KD Pharma
7.1.1 KD Pharma Details
7.1.2 KD Pharma Major Business
7.1.3 KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.1.4 KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 KD Pharma Recent Developments/Updates
7.1.6 KD Pharma Competitive Strengths & Weaknesses
7.2 Nippon Suisan Kaisha
7.2.1 Nippon Suisan Kaisha Details
7.2.2 Nippon Suisan Kaisha Major Business
7.2.3 Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.2.4 Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Nippon Suisan Kaisha Recent Developments/Updates
7.2.6 Nippon Suisan Kaisha Competitive Strengths & Weaknesses
7.3 Bizen Chemical
7.3.1 Bizen Chemical Details
7.3.2 Bizen Chemical Major Business
7.3.3 Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.3.4 Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bizen Chemical Recent Developments/Updates
7.3.6 Bizen Chemical Competitive Strengths & Weaknesses
7.4 AK Biopharm
7.4.1 AK Biopharm Details
7.4.2 AK Biopharm Major Business
7.4.3 AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.4.4 AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 AK Biopharm Recent Developments/Updates
7.4.6 AK Biopharm Competitive Strengths & Weaknesses
7.5 Maruha Nichiro
7.5.1 Maruha Nichiro Details
7.5.2 Maruha Nichiro Major Business
7.5.3 Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.5.4 Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Maruha Nichiro Recent Developments/Updates
7.5.6 Maruha Nichiro Competitive Strengths & Weaknesses
7.6 Croda Pharma
7.6.1 Croda Pharma Details
7.6.2 Croda Pharma Major Business
7.6.3 Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.6.4 Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Croda Pharma Recent Developments/Updates
7.6.6 Croda Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pure EPA Active Pharmaceutical Ingredient (API) Industry Chain
8.2 Pure EPA Active Pharmaceutical Ingredient (API) Upstream Analysis
8.2.1 Pure EPA Active Pharmaceutical Ingredient (API) Core Raw Materials
8.2.2 Main Manufacturers of Pure EPA Active Pharmaceutical Ingredient (API) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pure EPA Active Pharmaceutical Ingredient (API) Production Mode
8.6 Pure EPA Active Pharmaceutical Ingredient (API) Procurement Model
8.7 Pure EPA Active Pharmaceutical Ingredient (API) Industry Sales Model and Sales Channels
8.7.1 Pure EPA Active Pharmaceutical Ingredient (API) Sales Model
8.7.2 Pure EPA Active Pharmaceutical Ingredient (API) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pure EPA Active Pharmaceutical Ingredient (API) Introduction
1.2 World Pure EPA Active Pharmaceutical Ingredient (API) Supply & Forecast
1.2.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value (2019 & 2023 & 2030)
1.2.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.2.3 World Pure EPA Active Pharmaceutical Ingredient (API) Pricing Trends (2019-2030)
1.3 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Region (Based on Production Site)
1.3.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Region (2019-2030)
1.3.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Region (2019-2030)
1.3.3 World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Region (2019-2030)
1.3.4 North America Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.3.5 Europe Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.3.6 Japan Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.3.7 South Korea Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pure EPA Active Pharmaceutical Ingredient (API) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pure EPA Active Pharmaceutical Ingredient (API) Major Market Trends
2 DEMAND SUMMARY
2.1 World Pure EPA Active Pharmaceutical Ingredient (API) Demand (2019-2030)
2.2 World Pure EPA Active Pharmaceutical Ingredient (API) Consumption by Region
2.2.1 World Pure EPA Active Pharmaceutical Ingredient (API) Consumption by Region (2019-2024)
2.2.2 World Pure EPA Active Pharmaceutical Ingredient (API) Consumption Forecast by Region (2025-2030)
2.3 United States Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.4 China Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.5 Europe Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.6 Japan Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.7 South Korea Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.8 ASEAN Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
2.9 India Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030)
3 WORLD PURE EPA ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Manufacturer (2019-2024)
3.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Manufacturer (2019-2024)
3.3 World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Manufacturer (2019-2024)
3.4 Pure EPA Active Pharmaceutical Ingredient (API) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pure EPA Active Pharmaceutical Ingredient (API) in 2023
3.5.3 Global Concentration Ratios (CR8) for Pure EPA Active Pharmaceutical Ingredient (API) in 2023
3.6 Pure EPA Active Pharmaceutical Ingredient (API) Market: Overall Company Footprint Analysis
3.6.1 Pure EPA Active Pharmaceutical Ingredient (API) Market: Region Footprint
3.6.2 Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Type Footprint
3.6.3 Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Value Comparison
4.1.1 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Comparison
4.2.1 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Consumption Comparison
4.3.1 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value (2019-2024)
4.4.3 United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024)
4.5 China Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers and Market Share
4.5.1 China Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value (2019-2024)
4.5.3 China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024)
4.6 Rest of World Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Pure EPA Active Pharmaceutical Ingredient (API) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Purity 96.5%
5.2.2 Purity 99%
5.3 Market Segment by Type
5.3.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Type (2019-2030)
5.3.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type (2019-2030)
5.3.3 World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pure EPA Active Pharmaceutical Ingredient (API) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hypolipidemic Drugs
6.2.2 Cardiovascular Disease Drugs
6.3 Market Segment by Application
6.3.1 World Pure EPA Active Pharmaceutical Ingredient (API) Production by Application (2019-2030)
6.3.2 World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application (2019-2030)
6.3.3 World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 KD Pharma
7.1.1 KD Pharma Details
7.1.2 KD Pharma Major Business
7.1.3 KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.1.4 KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 KD Pharma Recent Developments/Updates
7.1.6 KD Pharma Competitive Strengths & Weaknesses
7.2 Nippon Suisan Kaisha
7.2.1 Nippon Suisan Kaisha Details
7.2.2 Nippon Suisan Kaisha Major Business
7.2.3 Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.2.4 Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Nippon Suisan Kaisha Recent Developments/Updates
7.2.6 Nippon Suisan Kaisha Competitive Strengths & Weaknesses
7.3 Bizen Chemical
7.3.1 Bizen Chemical Details
7.3.2 Bizen Chemical Major Business
7.3.3 Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.3.4 Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bizen Chemical Recent Developments/Updates
7.3.6 Bizen Chemical Competitive Strengths & Weaknesses
7.4 AK Biopharm
7.4.1 AK Biopharm Details
7.4.2 AK Biopharm Major Business
7.4.3 AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.4.4 AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 AK Biopharm Recent Developments/Updates
7.4.6 AK Biopharm Competitive Strengths & Weaknesses
7.5 Maruha Nichiro
7.5.1 Maruha Nichiro Details
7.5.2 Maruha Nichiro Major Business
7.5.3 Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.5.4 Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Maruha Nichiro Recent Developments/Updates
7.5.6 Maruha Nichiro Competitive Strengths & Weaknesses
7.6 Croda Pharma
7.6.1 Croda Pharma Details
7.6.2 Croda Pharma Major Business
7.6.3 Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
7.6.4 Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Croda Pharma Recent Developments/Updates
7.6.6 Croda Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pure EPA Active Pharmaceutical Ingredient (API) Industry Chain
8.2 Pure EPA Active Pharmaceutical Ingredient (API) Upstream Analysis
8.2.1 Pure EPA Active Pharmaceutical Ingredient (API) Core Raw Materials
8.2.2 Main Manufacturers of Pure EPA Active Pharmaceutical Ingredient (API) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pure EPA Active Pharmaceutical Ingredient (API) Production Mode
8.6 Pure EPA Active Pharmaceutical Ingredient (API) Procurement Model
8.7 Pure EPA Active Pharmaceutical Ingredient (API) Industry Sales Model and Sales Channels
8.7.1 Pure EPA Active Pharmaceutical Ingredient (API) Sales Model
8.7.2 Pure EPA Active Pharmaceutical Ingredient (API) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Region (2019-2024) & (USD Million)
Table 3. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Region (2025-2030) & (USD Million)
Table 4. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Region (2019-2024)
Table 5. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Region (2025-2030)
Table 6. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Region (2019-2024) & (Tons)
Table 7. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Region (2025-2030) & (Tons)
Table 8. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Region (2019-2024)
Table 9. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Region (2025-2030)
Table 10. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Region (2019-2024) & (US$/Kg)
Table 11. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Region (2025-2030) & (US$/Kg)
Table 12. Pure EPA Active Pharmaceutical Ingredient (API) Major Market Trends
Table 13. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Tons)
Table 14. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption by Region (2019-2024) & (Tons)
Table 15. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption Forecast by Region (2025-2030) & (Tons)
Table 16. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Pure EPA Active Pharmaceutical Ingredient (API) Producers in 2023
Table 18. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Manufacturer (2019-2024) & (Tons)
Table 19. Production Market Share of Key Pure EPA Active Pharmaceutical Ingredient (API) Producers in 2023
Table 20. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 21. Global Pure EPA Active Pharmaceutical Ingredient (API) Company Evaluation Quadrant
Table 22. World Pure EPA Active Pharmaceutical Ingredient (API) Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Pure EPA Active Pharmaceutical Ingredient (API) Production Site of Key Manufacturer
Table 24. Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Type Footprint
Table 25. Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Application Footprint
Table 26. Pure EPA Active Pharmaceutical Ingredient (API) Competitive Factors
Table 27. Pure EPA Active Pharmaceutical Ingredient (API) New Entrant and Capacity Expansion Plans
Table 28. Pure EPA Active Pharmaceutical Ingredient (API) Mergers & Acquisitions Activity
Table 29. United States VS China Pure EPA Active Pharmaceutical Ingredient (API) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Pure EPA Active Pharmaceutical Ingredient (API) Production Comparison, (2019 & 2023 & 2030) & (Tons)
Table 31. United States VS China Pure EPA Active Pharmaceutical Ingredient (API) Consumption Comparison, (2019 & 2023 & 2030) & (Tons)
Table 32. United States Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024) & (Tons)
Table 36. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share (2019-2024)
Table 37. China Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024) & (Tons)
Table 41. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share (2019-2024)
Table 42. Rest of World Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024) & (Tons)
Table 46. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share (2019-2024)
Table 47. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Type (2019-2024) & (Tons)
Table 49. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Type (2025-2030) & (Tons)
Table 50. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type (2019-2024) & (USD Million)
Table 51. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type (2025-2030) & (USD Million)
Table 52. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2019-2024) & (US$/Kg)
Table 53. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2025-2030) & (US$/Kg)
Table 54. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Application (2019-2024) & (Tons)
Table 56. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Application (2025-2030) & (Tons)
Table 57. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application (2019-2024) & (USD Million)
Table 58. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application (2025-2030) & (USD Million)
Table 59. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2019-2024) & (US$/Kg)
Table 60. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2025-2030) & (US$/Kg)
Table 61. KD Pharma Basic Information, Manufacturing Base and Competitors
Table 62. KD Pharma Major Business
Table 63. KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 64. KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. KD Pharma Recent Developments/Updates
Table 66. KD Pharma Competitive Strengths & Weaknesses
Table 67. Nippon Suisan Kaisha Basic Information, Manufacturing Base and Competitors
Table 68. Nippon Suisan Kaisha Major Business
Table 69. Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 70. Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Nippon Suisan Kaisha Recent Developments/Updates
Table 72. Nippon Suisan Kaisha Competitive Strengths & Weaknesses
Table 73. Bizen Chemical Basic Information, Manufacturing Base and Competitors
Table 74. Bizen Chemical Major Business
Table 75. Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 76. Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bizen Chemical Recent Developments/Updates
Table 78. Bizen Chemical Competitive Strengths & Weaknesses
Table 79. AK Biopharm Basic Information, Manufacturing Base and Competitors
Table 80. AK Biopharm Major Business
Table 81. AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 82. AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. AK Biopharm Recent Developments/Updates
Table 84. AK Biopharm Competitive Strengths & Weaknesses
Table 85. Maruha Nichiro Basic Information, Manufacturing Base and Competitors
Table 86. Maruha Nichiro Major Business
Table 87. Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 88. Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Maruha Nichiro Recent Developments/Updates
Table 90. Croda Pharma Basic Information, Manufacturing Base and Competitors
Table 91. Croda Pharma Major Business
Table 92. Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 93. Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Pure EPA Active Pharmaceutical Ingredient (API) Upstream (Raw Materials)
Table 95. Pure EPA Active Pharmaceutical Ingredient (API) Typical Customers
Table 96. Pure EPA Active Pharmaceutical Ingredient (API) Typical Distributors
LIST OF FIGURE
Figure 1. Pure EPA Active Pharmaceutical Ingredient (API) Picture
Figure 2. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 5. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price (2019-2030) & (US$/Kg)
Figure 6. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Region (2019-2030)
Figure 7. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Region (2019-2030)
Figure 8. North America Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 9. Europe Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 10. Japan Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 11. South Korea Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 12. Pure EPA Active Pharmaceutical Ingredient (API) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 15. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption Market Share by Region (2019-2030)
Figure 16. United States Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 17. China Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 18. Europe Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 19. Japan Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 20. South Korea Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 21. ASEAN Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 22. India Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 23. Producer Shipments of Pure EPA Active Pharmaceutical Ingredient (API) by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pure EPA Active Pharmaceutical Ingredient (API) Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pure EPA Active Pharmaceutical Ingredient (API) Markets in 2023
Figure 26. United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share 2023
Figure 30. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share 2023
Figure 32. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Type in 2023
Figure 34. Purity 96.5%
Figure 35. Purity 99%
Figure 36. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Type (2019-2030)
Figure 37. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Type (2019-2030)
Figure 38. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2019-2030) & (US$/Kg)
Figure 39. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Application in 2023
Figure 41. Hypolipidemic Drugs
Figure 42. Cardiovascular Disease Drugs
Figure 43. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Application (2019-2030)
Figure 44. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Application (2019-2030)
Figure 45. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2019-2030) & (US$/Kg)
Figure 46. Pure EPA Active Pharmaceutical Ingredient (API) Industry Chain
Figure 47. Pure EPA Active Pharmaceutical Ingredient (API) Procurement Model
Figure 48. Pure EPA Active Pharmaceutical Ingredient (API) Sales Model
Figure 49. Pure EPA Active Pharmaceutical Ingredient (API) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Region (2019-2024) & (USD Million)
Table 3. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Region (2025-2030) & (USD Million)
Table 4. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Region (2019-2024)
Table 5. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Region (2025-2030)
Table 6. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Region (2019-2024) & (Tons)
Table 7. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Region (2025-2030) & (Tons)
Table 8. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Region (2019-2024)
Table 9. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Region (2025-2030)
Table 10. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Region (2019-2024) & (US$/Kg)
Table 11. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Region (2025-2030) & (US$/Kg)
Table 12. Pure EPA Active Pharmaceutical Ingredient (API) Major Market Trends
Table 13. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Tons)
Table 14. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption by Region (2019-2024) & (Tons)
Table 15. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption Forecast by Region (2025-2030) & (Tons)
Table 16. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Pure EPA Active Pharmaceutical Ingredient (API) Producers in 2023
Table 18. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Manufacturer (2019-2024) & (Tons)
Table 19. Production Market Share of Key Pure EPA Active Pharmaceutical Ingredient (API) Producers in 2023
Table 20. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 21. Global Pure EPA Active Pharmaceutical Ingredient (API) Company Evaluation Quadrant
Table 22. World Pure EPA Active Pharmaceutical Ingredient (API) Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Pure EPA Active Pharmaceutical Ingredient (API) Production Site of Key Manufacturer
Table 24. Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Type Footprint
Table 25. Pure EPA Active Pharmaceutical Ingredient (API) Market: Company Product Application Footprint
Table 26. Pure EPA Active Pharmaceutical Ingredient (API) Competitive Factors
Table 27. Pure EPA Active Pharmaceutical Ingredient (API) New Entrant and Capacity Expansion Plans
Table 28. Pure EPA Active Pharmaceutical Ingredient (API) Mergers & Acquisitions Activity
Table 29. United States VS China Pure EPA Active Pharmaceutical Ingredient (API) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Pure EPA Active Pharmaceutical Ingredient (API) Production Comparison, (2019 & 2023 & 2030) & (Tons)
Table 31. United States VS China Pure EPA Active Pharmaceutical Ingredient (API) Consumption Comparison, (2019 & 2023 & 2030) & (Tons)
Table 32. United States Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024) & (Tons)
Table 36. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share (2019-2024)
Table 37. China Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024) & (Tons)
Table 41. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share (2019-2024)
Table 42. Rest of World Based Pure EPA Active Pharmaceutical Ingredient (API) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2024) & (Tons)
Table 46. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share (2019-2024)
Table 47. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Type (2019-2024) & (Tons)
Table 49. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Type (2025-2030) & (Tons)
Table 50. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type (2019-2024) & (USD Million)
Table 51. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type (2025-2030) & (USD Million)
Table 52. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2019-2024) & (US$/Kg)
Table 53. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2025-2030) & (US$/Kg)
Table 54. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Application (2019-2024) & (Tons)
Table 56. World Pure EPA Active Pharmaceutical Ingredient (API) Production by Application (2025-2030) & (Tons)
Table 57. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application (2019-2024) & (USD Million)
Table 58. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application (2025-2030) & (USD Million)
Table 59. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2019-2024) & (US$/Kg)
Table 60. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2025-2030) & (US$/Kg)
Table 61. KD Pharma Basic Information, Manufacturing Base and Competitors
Table 62. KD Pharma Major Business
Table 63. KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 64. KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. KD Pharma Recent Developments/Updates
Table 66. KD Pharma Competitive Strengths & Weaknesses
Table 67. Nippon Suisan Kaisha Basic Information, Manufacturing Base and Competitors
Table 68. Nippon Suisan Kaisha Major Business
Table 69. Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 70. Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Nippon Suisan Kaisha Recent Developments/Updates
Table 72. Nippon Suisan Kaisha Competitive Strengths & Weaknesses
Table 73. Bizen Chemical Basic Information, Manufacturing Base and Competitors
Table 74. Bizen Chemical Major Business
Table 75. Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 76. Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bizen Chemical Recent Developments/Updates
Table 78. Bizen Chemical Competitive Strengths & Weaknesses
Table 79. AK Biopharm Basic Information, Manufacturing Base and Competitors
Table 80. AK Biopharm Major Business
Table 81. AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 82. AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. AK Biopharm Recent Developments/Updates
Table 84. AK Biopharm Competitive Strengths & Weaknesses
Table 85. Maruha Nichiro Basic Information, Manufacturing Base and Competitors
Table 86. Maruha Nichiro Major Business
Table 87. Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 88. Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Maruha Nichiro Recent Developments/Updates
Table 90. Croda Pharma Basic Information, Manufacturing Base and Competitors
Table 91. Croda Pharma Major Business
Table 92. Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product and Services
Table 93. Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Pure EPA Active Pharmaceutical Ingredient (API) Upstream (Raw Materials)
Table 95. Pure EPA Active Pharmaceutical Ingredient (API) Typical Customers
Table 96. Pure EPA Active Pharmaceutical Ingredient (API) Typical Distributors
LIST OF FIGURE
Figure 1. Pure EPA Active Pharmaceutical Ingredient (API) Picture
Figure 2. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 5. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price (2019-2030) & (US$/Kg)
Figure 6. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Region (2019-2030)
Figure 7. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Region (2019-2030)
Figure 8. North America Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 9. Europe Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 10. Japan Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 11. South Korea Pure EPA Active Pharmaceutical Ingredient (API) Production (2019-2030) & (Tons)
Figure 12. Pure EPA Active Pharmaceutical Ingredient (API) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 15. World Pure EPA Active Pharmaceutical Ingredient (API) Consumption Market Share by Region (2019-2030)
Figure 16. United States Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 17. China Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 18. Europe Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 19. Japan Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 20. South Korea Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 21. ASEAN Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 22. India Pure EPA Active Pharmaceutical Ingredient (API) Consumption (2019-2030) & (Tons)
Figure 23. Producer Shipments of Pure EPA Active Pharmaceutical Ingredient (API) by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pure EPA Active Pharmaceutical Ingredient (API) Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pure EPA Active Pharmaceutical Ingredient (API) Markets in 2023
Figure 26. United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Pure EPA Active Pharmaceutical Ingredient (API) Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share 2023
Figure 30. China Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share 2023
Figure 32. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Type in 2023
Figure 34. Purity 96.5%
Figure 35. Purity 99%
Figure 36. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Type (2019-2030)
Figure 37. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Type (2019-2030)
Figure 38. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Type (2019-2030) & (US$/Kg)
Figure 39. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Application in 2023
Figure 41. Hypolipidemic Drugs
Figure 42. Cardiovascular Disease Drugs
Figure 43. World Pure EPA Active Pharmaceutical Ingredient (API) Production Market Share by Application (2019-2030)
Figure 44. World Pure EPA Active Pharmaceutical Ingredient (API) Production Value Market Share by Application (2019-2030)
Figure 45. World Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Application (2019-2030) & (US$/Kg)
Figure 46. Pure EPA Active Pharmaceutical Ingredient (API) Industry Chain
Figure 47. Pure EPA Active Pharmaceutical Ingredient (API) Procurement Model
Figure 48. Pure EPA Active Pharmaceutical Ingredient (API) Sales Model
Figure 49. Pure EPA Active Pharmaceutical Ingredient (API) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
